M. Frankel

The Ischemic Stroke Genetics Study (ISGS) Protocol

Scott Silliman, John Hardy, Stephen S Rich, 2003, BMC neurology.

Progesterone treatment does not decrease serum levels of biomarkers of glial and neuronal cell injury in moderate and severe TBI subjects: A secondary analysis of the Progesterone for Traumatic Brain Injury, Experimental Clinical Treatment (ProTECT) III trial.

R. Silbergleit, W. Barsan, J. Bazarian, 2020, Journal of neurotrauma.

Very early administration of progesterone for acute traumatic brain injury.

David W Wright, Yuko Y Palesch, Geoffrey T Manley, 2014, The New England journal of medicine.

Allogeneic Umbilical Cord Blood Infusion for Adults with Ischemic Stroke: Clinical Outcomes from a Phase I Safety Study

J. Troy, Rebecca Durham, J. Kurtzberg, 2018, Stem cells translational medicine.

The Effect of Goal-Directed Therapy on Patient Morbidity and Mortality After Traumatic Brain Injury: Results From the Progesterone for the Treatment of Traumatic Brain Injury III Clinical Trial*

Lisa H. Merck, G. Manley, R. Conwit, 2019, Critical care medicine.

Association of Very Early Serum Levels of S100B, Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and Spectrin Breakdown Product with Outcome in ProTECT III

Lisa H. Merck, R. Silbergleit, A. Jeromin, 2019, Journal of Neurotrauma.

Very early administration of progesterone for acute traumatic brain injury.

Lisa H. Merck, G. Manley, V. Hertzberg, 2014, The New England journal of medicine.